In recent years, many studies have shown that dual leucine zipper kinase (DLK, also known as MAP3K12) is an important biomarker and a potential target in neurodegenerative diseases (Le Pichon et al. 2017; Siu et al. 2018; Welsbie et al. 2017). Here, MAP3K12 is linked to neurodegenerative disease.